Deltamethrin a.i. 0.2 g/tablet and when determined the average measured content shall not differ from that declared by more than ± 12.5%.
(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane carboxylate
The material shall consist of a homogeneous mixture of technical deltamethrin, complying with the requirements of WHO specification 333/TC (April 2005), together with carriers and any other necessary formulants (including an embittering agent). The formulation shall be of dry tables, free from visible extraneous matter and individually packed in a blister pack.
The pH of an aqueous dispersion (1%) shall be 4.0 to 7.5.
Maximum: 2.5 min
Minimum: 30 N (newtons)
Maximum: 80 N (newtons)
Stability at elevated temperature
After storage at 54 ± 2°C for 14 days without pressure, the determined average active ingredient content must not be lower than 95% relative to the determined mean content found before storage and the formulation shall continue to comply with the clauses for:
-Degree of attrition